Clinical Trials Browser

Phase 2 × sipuleucel-T × 90 days × Clear all

NCT05751941 2026-03-16

Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms